Cogstate Management

Management criteria checks 3/4

Cogstate's CEO is Brad O'Connor, appointed in Dec 2005, has a tenure of 18.25 years. total yearly compensation is $1.10M, comprised of 33.1% salary and 66.9% bonuses, including company stock and options. directly owns 2.59% of the company’s shares, worth A$5.99M. The average tenure of the management team and the board of directors is 3.1 years and 3.3 years respectively.

Key information

Brad O'Connor

Chief executive officer

US$1.1m

Total compensation

CEO salary percentage33.1%
CEO tenure18.3yrs
CEO ownership2.6%
Management average tenure3.1yrs
Board average tenure3.3yrs

Recent management updates

Recent updates

The Price Is Right For Cogstate Limited (ASX:CGS)

Jan 17
The Price Is Right For Cogstate Limited (ASX:CGS)

Is Cogstate Limited (ASX:CGS) Trading At A 29% Discount?

Jul 26
Is Cogstate Limited (ASX:CGS) Trading At A 29% Discount?

Returns Are Gaining Momentum At Cogstate (ASX:CGS)

Apr 14
Returns Are Gaining Momentum At Cogstate (ASX:CGS)

Growth Investors: Industry Analysts Just Upgraded Their Cogstate Limited (ASX:CGS) Revenue Forecasts By 11%

Mar 23
Growth Investors: Industry Analysts Just Upgraded Their Cogstate Limited (ASX:CGS) Revenue Forecasts By 11%

Earnings Update: Cogstate Limited (ASX:CGS) Just Reported And Analysts Are Trimming Their Forecasts

Mar 02
Earnings Update: Cogstate Limited (ASX:CGS) Just Reported And Analysts Are Trimming Their Forecasts

Cogstate Limited (ASX:CGS) Shares Could Be 19% Below Their Intrinsic Value Estimate

Jan 13
Cogstate Limited (ASX:CGS) Shares Could Be 19% Below Their Intrinsic Value Estimate

Investors Appear Satisfied With Cogstate Limited's (ASX:CGS) Prospects As Shares Rocket 51%

Oct 04
Investors Appear Satisfied With Cogstate Limited's (ASX:CGS) Prospects As Shares Rocket 51%

Do Cogstate's (ASX:CGS) Earnings Warrant Your Attention?

Sep 28
Do Cogstate's (ASX:CGS) Earnings Warrant Your Attention?

Returns On Capital Are A Standout For Cogstate (ASX:CGS)

Sep 02
Returns On Capital Are A Standout For Cogstate (ASX:CGS)

We Ran A Stock Scan For Earnings Growth And Cogstate (ASX:CGS) Passed With Ease

Jun 30
We Ran A Stock Scan For Earnings Growth And Cogstate (ASX:CGS) Passed With Ease

Investors Should Be Encouraged By Cogstate's (ASX:CGS) Returns On Capital

Mar 22
Investors Should Be Encouraged By Cogstate's (ASX:CGS) Returns On Capital

We Think Some Shareholders May Hesitate To Increase Cogstate Limited's (ASX:CGS) CEO Compensation

Oct 20
We Think Some Shareholders May Hesitate To Increase Cogstate Limited's (ASX:CGS) CEO Compensation

Cogstate (ASX:CGS) Is Looking To Continue Growing Its Returns On Capital

Jul 23
Cogstate (ASX:CGS) Is Looking To Continue Growing Its Returns On Capital

Is Cogstate (ASX:CGS) Using Too Much Debt?

Apr 29
Is Cogstate (ASX:CGS) Using Too Much Debt?

What Can The Trends At Cogstate (ASX:CGS) Tell Us About Their Returns?

Mar 14
What Can The Trends At Cogstate (ASX:CGS) Tell Us About Their Returns?

Here's What Cogstate Limited's (ASX:CGS) Shareholder Ownership Structure Looks Like

Feb 21
Here's What Cogstate Limited's (ASX:CGS) Shareholder Ownership Structure Looks Like

How Much Is Cogstate's (ASX:CGS) CEO Getting Paid?

Jan 17
How Much Is Cogstate's (ASX:CGS) CEO Getting Paid?

Can You Imagine How Jubilant Cogstate's (ASX:CGS) Shareholders Feel About Its 214% Share Price Gain?

Dec 05
Can You Imagine How Jubilant Cogstate's (ASX:CGS) Shareholders Feel About Its 214% Share Price Gain?

CEO Compensation Analysis

How has Brad O'Connor's remuneration changed compared to Cogstate's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

US$6m

Sep 30 2023n/an/a

US$5m

Jun 30 2023US$1mUS$363k

US$4m

Mar 31 2023n/an/a

US$4m

Dec 31 2022n/an/a

US$3m

Sep 30 2022n/an/a

US$6m

Jun 30 2022US$2mUS$346k

US$8m

Mar 31 2022n/an/a

US$9m

Dec 31 2021n/an/a

US$10m

Sep 30 2021n/an/a

US$7m

Jun 30 2021US$1mUS$344k

US$5m

Mar 31 2021n/an/a

US$3m

Dec 31 2020n/an/a

US$335k

Sep 30 2020n/an/a

-US$811k

Jun 30 2020US$931kUS$371k

-US$2m

Mar 31 2020n/an/a

-US$3m

Dec 31 2019n/an/a

-US$3m

Sep 30 2019n/an/a

-US$3m

Jun 30 2019US$655kUS$368k

-US$2m

Mar 31 2019n/an/a

-US$2m

Dec 31 2018n/an/a

-US$1m

Sep 30 2018n/an/a

-US$907k

Jun 30 2018US$783kUS$338k

-US$566k

Mar 31 2018n/an/a

-US$2m

Dec 31 2017n/an/a

-US$3m

Sep 30 2017n/an/a

-US$2m

Jun 30 2017US$616kUS$296k

-US$643k

Compensation vs Market: Brad's total compensation ($USD1.10M) is above average for companies of similar size in the Australian market ($USD628.46K).

Compensation vs Earnings: Brad's compensation has been consistent with company performance over the past year.


CEO

Brad O'Connor

18.3yrs

Tenure

US$1,098,299

Compensation

Mr. Bradley John O'Connor, also known as Brad, B.Bus, CA, has been the Chief Executive Officer and Managing Director of Cogstate Limited since December 1, 2005 and served as its Chief Financial Officer sin...


Leadership Team

NamePositionTenureCompensationOwnership
Bradley O'Connor
CEO, MD & Executive Director18.3yrsUS$1.10m2.59%
$ 6.0m
Paul Maruff
Founder & Chief Innovation Officerno datano datano data
Darren Watson
Chief Financial Officer3.1yrsUS$469.06kno data
Benjamin Bloomfield
Chief Technology Officer3.2yrsUS$311.03kno data
Chris Edgar
Chief Science Officer3.4yrsUS$421.93k0.029%
$ 67.5k
Kenneth Billard
Chief Commercial Officer4.3yrsUS$436.14kno data
Rachel Colite
Executive VP of Clinical Trialsless than a yearUS$302.28k0.058%
$ 135.0k
Kristi Geddes
General Counselless than a yearno datano data
David Franks
Joint Company Secretary3.1yrsno datano data

3.1yrs

Average Tenure

Experienced Management: CGS's management team is considered experienced (3.1 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Bradley O'Connor
CEO, MD & Executive Director18.3yrsUS$1.10m2.59%
$ 6.0m
Kristi Geddes
General Counselno datano datano data
Richard van den Broek
Independent Non-Executive Director13.6yrsUS$56.15k2.6%
$ 6.0m
Martyn Myer
Non-Executive Chairman24.3yrsUS$94.62k27.1%
$ 62.7m
Ingrid Player
Independent Non-Executive Director4.6yrsUS$70.97k0.078%
$ 181.0k
Kim Wenn
Independent Non-Executive Director3.3yrsUS$64.21k0.0073%
$ 17.0k
Richard Mohs
Independent Non-Executive Director7.2yrsUS$62.76k0.039%
$ 90.5k
Sharon Cohen
Member of Scientific Advisory Board1.8yrsno datano data
Eric Siemers
Distinguished Medical Adviser & Chairman of Scientific Advisory Board1.8yrsno datano data
Bruce Albala
Member of Scientific Advisory Board1.8yrsno datano data
Adam Brickman
Member of Scientific Advisory Board1.8yrsno datano data
Kate Papp
Member of Scientific Advisory Board1.8yrsno datano data

3.3yrs

Average Tenure

61yo

Average Age

Experienced Board: CGS's board of directors are considered experienced (3.3 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.